Publication: Two-year results of a community-based randomized controlled lifestyle intervention trial to control prehypertension and/or prediabetes in Thailand: A brief report
Issued Date
2019-01-01
Resource Type
ISSN
11787074
Other identifier(s)
2-s2.0-85067521641
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of General Medicine. Vol.12, (2019), 131-135
Suggested Citation
Supa Pengpid, Karl Peltzer, Isareethika Jayasvasti, Wichai Aekplakorn, Apa Puckpinyo, Pheeraya Nanthananate, Anutsara Mansin Two-year results of a community-based randomized controlled lifestyle intervention trial to control prehypertension and/or prediabetes in Thailand: A brief report. International Journal of General Medicine. Vol.12, (2019), 131-135. doi:10.2147/IJGM.S200086 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/52345
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Two-year results of a community-based randomized controlled lifestyle intervention trial to control prehypertension and/or prediabetes in Thailand: A brief report
Other Contributor(s)
Abstract
© 2019 Pengpid et al. The aim of the study was to assess the 2-year effect of a community-based randomized controlled lifestyle intervention on glucose and blood pressure levels in Thailand. Participants (N=443, with prediabetes and/or prehypertension) received a six 2-hr group sessions lifestyle intervention (physical activity and nutrition) over 6 months. Measurements were at baseline, 12 months (89%) and at 24 months (84.7%). Statistically significant interaction effects on fasting plasma glucose and DBP at 12 months were not maintained at 24 months, while significant interaction effects were found on high-density lipoprotein and low-density lipoprotein cholesterol at 24 months. Improvements were found for fasting plasma glucose, SBP, DBP and total cholesterol, but no significant interaction effect was detected. The development of type 2 diabetes was higher in the control than in the intervention group, but it was not reaching significance (P=0.181), while 3.0% in the intervention group and 2.6% in the control group developed hypertension at 24 months. No significant group differences were found in psycho-behavioral variables. The lifestyle intervention did not provide additional benefits compared to the control group at 24-month follow-up. Trial registration number: TCTR20170721001.